FTC Charges Agreement Between Hoechst Marion Roussel and ANDRX Corp. To Delay Entry of Generic Competition for Cardizem CD Violates Antitrust Laws;

Proposed Settlement with Abbott Laboratories and Geneva Pharmaceuticals to Resolve Similar Charges over Generic Version of Abbott's Hytrin

Share This Page

Media Advisory



What: The Federal Trade Commission will hold a news conference to announce law enforcement actions involving brand name and generic pharmaceutical manufacturers.
When: Thursday, March 16, at 1:30 p.m.
Who: Richard G. Parker, Director
FTC Bureau of Competition
Where: Federal Trade Commission
Room 432
600 Pennsylvania Ave., NW
Washington, D.C. 20580
Contact: Mitchell J. Katz or Howard Shapiro
FTC Office of Public Affairs
202-326-2161 or 202-326-2176

Listen Only: Reporters unable to attend may listen to the event by calling: 1-888-790-3103.

Room 432 will open at 12:45 pm to allow camera crews time to set up.

Contact Information